Proteome Sciences plc (AIM:PRM)
London · Delayed Price · Currency is GBP · Price in GBX 1.400
-0.255 (-15.41%)
May 8, 2026, 4:40 PM GMT
Proteome Sciences Revenue
In the year 2025, Proteome Sciences had annual revenue of 3.76M GBP, down -23.14%. Proteome Sciences had revenue of 1.90M in the half year ending December 31, 2025, with 4.46% growth.
Revenue
3.76M
Revenue Growth
-23.14%
P/S Ratio
1.31
Revenue / Employee
117.38K
Employees
32
Market Cap
4.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.76M | -1.13M | -23.14% |
| Dec 31, 2024 | 4.89M | -141.00K | -2.80% |
| Dec 31, 2023 | 5.03M | -2.75M | -35.37% |
| Dec 31, 2022 | 7.78M | 2.65M | 51.69% |
| Dec 31, 2021 | 5.13M | 376.00K | 7.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 45.77B |
| GSK plc | 32.78B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Surgical Innovations Group | 11.60M |
| Cambridge Nutritional Sciences | 8.06M |
| OptiBiotix Health | 1.15M |
| CRISM Therapeutics | 25.00K |